3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma
1
Interventions
Injections
3
Doxorubicin
3
anlotinib
2
toripalimab
1
pemigatinib
1
pazopanib
1
montelukast
1
liposomal doxorubicin
1
eribulin
1
chlorhexidine gluconate
1
camrelizumab
1
bexmarilimab
1
apatinib
1
X-Rays
1
Trabectedin
1
Temozolomide
1
Tablets
1
Sodium Chloride
1
Radiotherapy
1
Proton Therapy
1
Positron Emission Tomography Computed Tomography
1
Nivolumab
1
Negative-Pressure Wound Therapy
1
KP 1339
1
Ipilimumab
1
Immunotherapy
1
Heavy Ion Radiotherapy
1
Granulocyte Colony-Stimulating Factor
1
Epirubicin
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Sarcoma
×
bexmarilimab
×
Clear all
NCT07460986
2026-03-10
BEXAR
MedSIR
Phase 1/2
Not yet recruiting
278 enrolled